Patents by Inventor Alison E. Willing

Alison E. Willing has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Ischemic tissue cell therapy
    Patent number: 10335434
    Abstract: The present invention is directed to compositions and methods for treatment of ischemic diseases and conditions, particularly myocardial, CNS/brain and limb ischemia. More particularly, the present invention provides methods of treating disorders by administering monocytes obtained from blood, including umbilical cord blood, peripheral blood, or bone marrow to an individual in need of treatment, wherein the drug is administered to the individual at a time point specifically determined to provide therapeutic efficacy. In one embodiment, the cells are for injection into ischemic myocardium for the treatment of angina.
    Type: Grant
    Filed: July 21, 2014
    Date of Patent: July 2, 2019
    Assignee: University of South Florida
    Inventors: Paul R. Sanberg, Alison E. Willing
  • ISCHEMIC TISSUE CELL THERAPY
    Publication number: 20140369983
    Abstract: The present invention is directed to compositions and methods for treatment of ischemic diseases and conditions, particularly myocardial, CNS/brain and limb ischemia. More particularly, the present invention provides methods of treating disorders by administering monocytes obtained from blood, including umbilical cord blood, peripheral blood, or bone marrow to an individual in need of treatment, wherein the drug is administered to the individual at a time point specifically determined to provide therapeutic efficacy. In one embodiment, the cells are for injection into ischemic myocardium for the treatment of angina.
    Type: Application
    Filed: July 21, 2014
    Publication date: December 18, 2014
    Applicant: UNIVERSITY OF SOUTH FLORIDA
    Inventors: Paul R. Sanberg, Alison E. Willing
  • Ischemic tissue cell therapy
    Patent number: 8784802
    Abstract: The present invention is directed to compositions and methods for treatment of ischemic diseases and conditions, particularly myocardial, CNS/brain and limb ischemia. More particularly, the present invention provides methods of treating disorders by administering monocytes obtained from blood, including umbilical cord blood, peripheral blood, or bone marrow to an individual in need of treatment, wherein the drug is administered to the individual at a time point specifically determined to provide therapeutic efficacy. In one embodiment, the cells are for injection into ischemic myocardium for the treatment of angina.
    Type: Grant
    Filed: September 14, 2009
    Date of Patent: July 22, 2014
    Assignees: Cryopraxis Criobiologia Ltda., Universidade Federal de Sao Paulo—UNIFESP, University of South Florida
    Inventors: Paul R. Sanberg, Nelson Americo Hossne, Jr., Alison E. Willing, Adriana Invitti
  • ISCHEMIC TISSUE CELL THERAPY
    Publication number: 20110274674
    Abstract: The present invention is directed to compositions and methods for treatment of ischemic diseases and conditions, particularly myocardial, CNS/brain and limb ischemia. More particularly, the present invention provides methods of treating disorders by administering monocytes obtained from blood, including umbilical cord blood, peripheral blood, or bone marrow to an individual in need of treatment, wherein the drug is administered to the individual at a time point specifically determined to provide therapeutic efficacy. In one embodiment, the cells are for injection into ischemic myocardium for the treatment of angina.
    Type: Application
    Filed: September 14, 2009
    Publication date: November 10, 2011
    Applicants: Cryopraxis Criobiologia Ltda., University of South Florida, Universidade Federal de Sao Paulo - UNIFESP
    Inventors: Paul R. Sanberg, Nelson Americo Hossne, JR., Alison E. Willing, Andriana Invitti